Growth Metrics

Quest Diagnostics (DGX) Minority Interest (2016 - 2025)

Quest Diagnostics' Minority Interest history spans 17 years, with the latest figure at $36.0 million for Q4 2025.

  • For Q4 2025, Minority Interest fell 56.63% year-over-year to $36.0 million; the TTM value through Dec 2025 reached $36.0 million, down 56.63%, while the annual FY2025 figure was $36.0 million, 56.63% down from the prior year.
  • Minority Interest for Q4 2025 was $36.0 million at Quest Diagnostics, down from $81.0 million in the prior quarter.
  • Across five years, Minority Interest topped out at $83.0 million in Q4 2024 and bottomed at $36.0 million in Q4 2025.
  • The 5-year median for Minority Interest is $39.5 million (2021), against an average of $56.4 million.
  • The largest YoY upside for Minority Interest was 118.92% in 2025 against a maximum downside of 56.63% in 2025.
  • A 5-year view of Minority Interest shows it stood at $79.0 million in 2021, then plummeted by 53.16% to $37.0 million in 2022, then skyrocketed by 105.41% to $76.0 million in 2023, then grew by 9.21% to $83.0 million in 2024, then tumbled by 56.63% to $36.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Minority Interest are $36.0 million (Q4 2025), $81.0 million (Q3 2025), and $37.0 million (Q2 2025).